Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials
Titel:
Radium-223 in women with hormone receptor-positive bone-metastatic breast cancer receiving endocrine therapy: pooled analysis of two international, phase 2, randomized, double-blind, placebo-controlled trials
Auteur:
Rugo, Hope S. Van Poznak, Catherine H. Neven, Patrick Danielewicz, Iwona Lee, Soo Chin Campone, Mario Chik, Jeannie Y. K. Vega Alonso, Estela Naume, Bjørn Brain, Etienne Siegel, Jonathan M. Li, Rui Uema, Deise Wagner, Volker J. Coleman, Robert E.